Literature DB >> 33811640

Injured recipients of low-titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single-center, retrospective study.

Mark H Yazer1,2, Andrew Freeman1, Ian M Harrold1, Vincent Anto3, Matthew D Neal3,4, Darrell J Triulzi1,2, Jason L Sperry4, Jansen N Seheult1,2.   

Abstract

INTRODUCTION: Low-titer group O whole blood (LTOWB) is being increasingly transfused to injured patients. This study evaluated a range of clinical outcomes to determine if receipt of LTOWB predisposed recipients to worse outcomes compared to recipients of conventional component therapy (CCT).
METHODS: A retrospective analysis of trauma patients who received at least 3 units of LTOWB (LTOWB group) versus those that received at least 3 units of RBCs, 1 unit of plasma and 1 unit of platelets but no LTOWB (CCT group) during the first 24 h of their admission was performed. Causal treatment effects were explored using propensity score matching (PSM) and coarsened exact matching (CEM). Important clinical outcomes were evaluated.
RESULTS: There were 165 CCT and 155 LTOWB recipients eligible for matching. PSM and CEM reduced covariate imbalances between the CCT and LTOWB groups, with the exception that males remained over-represented in the LTOWB group due to the hospital's former resuscitation policy of not administering RhD-positive LTOWB to females <50. In both of the matched analyses, the LTOWB group received a median of 4 LTOWB units. There were no significant differences in 6-, 24-h mortality or 30-day mortality between groups, nor were there differences in the frequency of other clinical outcomes such as acute kidney injury, sepsis, venous/arterial thromboembolism; delta MODS was lower for the LTOWB recipients in the exact match group.
CONCLUSION: In both matched analyses, administration of a median of four LTOWB units did not result in a different frequency of major clinical outcomes including mortality.
© 2021 AABB.

Entities:  

Keywords:  adverse event; conventional components; low titer group O whole blood; mortality; safety; transfusion; trauma

Mesh:

Substances:

Year:  2021        PMID: 33811640     DOI: 10.1111/trf.16390

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Prehospital Whole Blood Transfusion Programs in Norway.

Authors:  Christopher Kalhagen Bjerkvig; Geir Strandenes; Tor Hervig; Geir Arne Sunde; Torunn Oveland Apelseth
Journal:  Transfus Med Hemother       Date:  2021-10-22       Impact factor: 3.747

2.  Recent Developments in Emergency Blood Transfusion.

Authors:  Hans-Gert Heuft; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-10-28       Impact factor: 3.747

3.  The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come.

Authors:  Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-11-02       Impact factor: 3.747

4.  Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial.

Authors:  Frank X Guyette; Mazen Zenati; Darrell J Triulzi; Mark H Yazer; Hunter Skroczky; Barbara J Early; Peter W Adams; Joshua B Brown; Louis Alarcon; Matthew D Neal; Raquel M Forsythe; Brian S Zuckerbraun; Andrew B Peitzman; Timothy R Billiar; Jason L Sperry
Journal:  J Trauma Acute Care Surg       Date:  2022-01-25       Impact factor: 3.697

Review 5.  The Role of Whole Blood Transfusions in Civilian Trauma: A Review of Literature in Military and Civilian Trauma.

Authors:  Shane Kronstedt; Joon Lee; David Millner; Connor Mattivi; Halli LaFrankie; Lorenzo Paladino; Jeffrey Siegler
Journal:  Cureus       Date:  2022-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.